Search Results | Showing 21 - 30 of 30 results for "Pfizer" |
| | | ... 0.85 per cent, to 4,854.7 points. NEW YORK - After two weeks of strong earnings pumped up the markets, weak results from Pfizer and others deflated a broad earnings rally, at least for Tuesday. The world's largest drug maker posted lower than expected ... |
| | | | ... Favourite stocks included Roche, which appeared in seven portfolios, tobacco maker Phillip Morris International, Nestle, Pfizer, Vodafone, Apple, Google, Hewlett Packard, Johnson & Johnson and Wells Fargo. Nine large cap funds made the highest rating ... |
| | | | ... had risen 15.46, or 0.55 per cent, to 2,784.76. The Dow and the S&P 500 surpassed significant milestones last week after Pfizer Inc, UPS Inc and other large companies reported higher earnings. There was also a strong report on manufacturing. The Dow ... |
| | | | ... in the healthcare, telecommunication and consumer staples industry sectors. Some of these include Nestle, pharmaceutical Pfizer and telco provider AT&T. Co-head of iShares Australia, Tim Bradbury, said the additional ETFs give investors more choice ... |
| | | | ... up from half a dozen in 2007. This included Wesfarmers (owner of Coles Group), security firm Chubb and healthcare group Pfizer. Two months ago, Mercer boosted its sales team further when it hired Heather Dawson as outsourcing sales leader for Australia ... |
| | | | ... that will deliver consistent and stable returns in the long term. Among the fund's top 10 holdings are Cadbury Schweppes, Pfizer and Reckitt Benckiser. In the year to date the fund has outperformed its benchmark and has returned 17.63 per cent over a ... |
| | | | ... sentiment was boosted by strong earnings and a positive outlook from Cisco and by news of a possible sale of drug company Pfizer's consumer division. The Dow Jones industrial average was up 108.86 points at 10,858.62. The Standard & Poor's 500 Index ... |
| | | | ... Advanced Micro Devices Inc. revived hopes for corporate earnings growth. A stronger-than-expected profit from Dow component Pfizer Inc. drove the drug maker's stock up 4.5 per cent to $25.08. The stock was the biggest contributor to gains in both the ... |
| | | | ... which helped drive stocks down sharply on Thursday, also weighed on the Dow. Shares of major drug companies, including Pfizer and Merck, declined as the sector faces generic competition and legal concerns about key medicines. The Dow Jones industrial ... |
| | | | ... down more than one per cent, after a key inflation gauge jumped to a 25-year high and stirred interest-rate worries, while Pfizer posted disappointing quarterly results. A drop of more than $US1 a barrel in crude oil prices hit shares of heavily weighted ... |
|